Optimal management of chemotherapy-induced thrombocytopenia with thrombopoietin receptor agonists
{{output}}
Chemotherapy-induced thrombocytopenia (CIT) is a common complication of antineoplastic therapy, resulting in antineoplastic therapy dose reductions, treatment delays, treatment discontinuation, and morbid bleeding events. Despite several decades of research in... ...
